Biothera Ingredient OK’d by TGA

EAGAN, Minn.—Biothera’s ingredient Wellmune WGP® has been approved for use in complementary medicine products in Australia by the country’s Therapeutic Goods Administration (TGA). Biothera worked closely with Pathway International, its distributor in Australia and New Zealand, to receive TGA’s regulatory approval. Wellmune WGP is a natural immune-enhancing compound isolated from the cell walls of a proprietary strain of yeast.